🇺🇸 FDA
Patent

US 11542504

Compounds and methods for modulating ATXN1

granted A61KA61K31/712A61K35/30

Quick answer

US patent 11542504 (Compounds and methods for modulating ATXN1) held by Ionis Pharmaceuticals, Inc. expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/712, A61K35/30, A61K47/02, A61P